在广泛使用的商业药物改造图书馆中,乱伦的生物活性化合物普遍存在
Huabin Hu1, James Bowers2, Justin Shumate3
1Central Hospital of Dalian University of Technology, Dalian, Liaoning, 116033, PR China; School of Pharmacy, Faculty of Medicine, Dalian University of Technology, Dalian, Liaoning, 116024, PR China.
European journal of medicinal chemistry
|January 6, 2026
概括
药物改造图书馆通常含有不规则的化合物,可以误导研究. 这项研究敦促严格验证,以防止推进无效的候选药物,并确保患者的安全.
科学领域:
- 药用化学 医学化学
- 药物发现 药物发现 药物发现
- 药理学 药理学是指药理学的学科.
背景情况:
- 药物发现依赖于选化合物的生物活性.
- 药物改用旨在通过使用已批准的药物来加速发展.
- 知识产权和监管障碍对药物的重新用途构成风险.
研究的目的:
- 为了确定药物重新利用图书馆中的有关现象.
- 为了突出滥用化合物在药物重新利用中的风险.
- 倡导在药物发现中改进验证过程.
主要方法:
- 对广泛使用的药物重新定位图书馆的分析.
- 识别杂乱的化合物和有问题的分子支架.
- 评估与误导性化合物相关的潜在风险.
主要成果:
- 药物改用图书馆不成比例地充斥着乱伦的化合物.
- 缺乏药用化学专业知识可能导致忽视虚假的化合物行为.
- 误导性化合物可能被推进到临床试验中,浪费资源并危及患者的安全.
结论:
- 严格验证选结果至关重要.
- 问题性化合物应该系统地被排除在药物重用图书馆之外.
- 改进的验证将提高药物重定向倡议的成功率.
更多相关视频
相关概念视频
Drug Discovery: Overview
10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Drug Biotransformation: Overview
3.6K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
3.6K
Drug Biotransformation: Overview
2.4K
Biotransformation, also known as drug metabolism, is a vital physiological process that chemically alters drugs, facilitating their elimination from the body and terminating their action. This process involves two main phases: phase I and phase II reactions. Phase I reactions, including oxidation, reduction, and hydrolysis, introduce or unmask polar functional groups on the drug molecule, thereby increasing its water solubility. By enhancing water solubility, the drug becomes more hydrophilic...
2.4K
Targets for Drug Action: Overview
10.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.0K
Principles of Drug Action
8.0K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
8.0K
Prodrugs
4.0K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
4.0K


